1. |
Das D, Arber N, Jankowski JA. Chemoprevention of colorectal cancer[J]. Digestion, 2007, 76(1): 51-67.
|
2. |
Wang MT, Honn KV, Nie D. Cyclooxygenases, prostanoids, and tumor progression[J]. Cancer Metastasis Rev, 2007, 26(3-4): 525-534.
|
3. |
姚小寶, 王曉俠, 張少強, 等. 抑制COX-2表達對逆轉喉癌惡性生物學行為的影響[J]. 西安交通大學學報(醫學版), 2009, 19(7): 671-673.
|
4. |
楊健, 胡為民, 任碧軒, 等. RNA干擾體外抑制HBeAg的表達[J]. 細胞與分子免疫學雜志, 2006, 22(5): 670-671, 673.
|
5. |
Brummelkamp TR, Bernards R, Agami R. Stable suppression of tumorigenicity by virus-mediated RNA interference[J]. Cancer Cell, 2002, 2(3): 243-247.
|
6. |
Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase[J]. Science, 1995, 269(5228): 1236-1241.
|
7. |
Gwyn K, Sinicrope F. Chemoprevention of colorectal cancer[J]. Am J Gastroenterol, 2002, 97(1): 13-21.
|
8. |
王磊, 陳衛昌, 謝學順, 等. 塞來昔布對實驗性結腸癌原位移植瘤生長及血管形成的影響[J]. 中華腫瘤防治雜志, 2006, 13(17): 1295-1300.
|
9. |
Chen Z, Zhang X, Li M, et al. Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxyg-enase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck[J]. Clin Cancer Res, 2004, 10(17): 5930-5939.
|
10. |
王晨, 費小凡. 饒丹, 等. 環氧化酶-2抑制劑致心血管系統的作用機制[J]. 華西醫學, 2011, 26(10): 1581-1584.
|
11. |
Brummelkamp TR, Bernards R. New tools for functional mammalian cancer genetics[J]. Nat Rev Cancer, 2003, 10(10): 781-789.
|
12. |
Barańska M, Skretkowicz J. Prospects of gene therapy[J]. Wiad Lek, 2007, 60(7-8): 305-311.
|
13. |
達明緒, 張明鳴, 羅婷, 等. 胃癌COX-2的表達與微血管密度及相關臨床病理因素的關系[J]. 華西醫學, 2005, 20(1): 12-14.
|
14. |
宋繼榮, 董穎, 潘月娜. 宮頸癌組織中Survivin和Cox-2的表達及相關性[J]. 黑龍江醫藥科學, 2012, 35(5): 36-38.
|
15. |
Masferrer JL, Leahy KM, Koki AT, et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors[J]. Cancer Res, 2000, 60(5): 1306-1311.
|
16. |
Gallo O, Franchi A, Magnelli L, et al. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis[J]. Neoplasia, 2001, 3(1): 53-61.
|
17. |
趙暉, 王樹成. RNA干擾沉默食管癌COX-2基因的實驗研究[J]. 山東大學學報:醫學版, 2006, 44(3): 256-259.
|
18. |
Suzuki O, Abe M. Cell surface N-glycosylation and sialylation regulate galectin-3-induced apoptosis in human diffuse large B cell lymphoma[J]. Oncol Rep, 2008, 19(3): 743-748.
|
19. |
Takai N, Ueda T, Nishida M, et al. Histone deacetylase inhibitors induce growth inhibition, cell cycle arrest and apoptosis in human choriocarcinoma cells[J]. Int J Mol Med, 2008, 21(1): 109-115.
|
20. |
Folkman J. Angiogenesis and apoptosis[J]. Cancer Biol, 2003, 13(2): 159-167.
|